Seres Therapeutics, Inc. (MCRB)
NASDAQ·Healthcare·Biotechnology
$1.69
-4.44%
Mkt Cap $83.09M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$12.00
Range $12.00 – $12.00
Implied Upside
+610.1%
Consensus $12.00 vs current $1.69
NASDAQ·Healthcare·Biotechnology
$1.69
-4.44%
Mkt Cap $83.09M
No recent rating data.
Price Target (2 analysts)
$12.00
Range $12.00 – $12.00
+610.1%
Consensus $12.00 vs current $1.69